We confirmed the absence of significant institutional heterogeneity for OS (I=0% P=0.76) and DSS (I=0% P=0.4).
At the end of the follow-up period, 657 patients (81.5%) had reached DSS 3, 543 patients (67.4%) DSS 6, 390 patients (48.4%) DSS 8 and 132 patients (16.4%) had reached DSS 10; the estimated median survival times were 10, 18, 28 and 63 years, respectively.
The DNA stocks solutions were prepared as the PCNA samples in the same buffer (except that no NaN3, DSS or 2H2O was added).
Each sample was cross-linked with increasing amounts of a heavy/light cross-linker (DSS-H12/D12; DSS) generating a total of 102 MS experiments using the three data-acquisition techniques (hrMS1, DDA, and DIA) (Supplementary Table 4).
Adverse events included patient ventilator asynchrony (n = 159 DSS), O2 desaturation (n = 119 DSS), accidental catheter removal (n = 22), fall (n = 9).
In [7, 8, 9], DSS was effectively integrated with the distribution network to realize the economic operation of the system.
We assessed 49 patients (27 DSS; 22 non-DSS) treated with volar locking plates, with a mean age of 59.9 years and average follow-up of 20.2 months (range 12 56 months).
As indicated, DSS children had significant lower relative neutrophil counts (median values / DF: 3900; DHF: 3950; DSS: 2500; p-value: 0.03; Kruskal Wallis test).
We confirmed the robustness of the DSS-gene signature using the iterative Support Vector Machine (SVM) classifier learning method [39], which reclassified all the 19 DSS patients together.
GLP-1: glucagon-like peptide-1; DSS: Dahl salt-sensitive; LS: low salt; HS: high salt; LV: left ventricular; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA-IR: homeostasis model assessment-insulin resistance; ACE: angiotensin-converting enzyme; RAAS: renin-angiotensin aldosterone system.
